Wipfli Financial Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Wipfli Financial Advisors’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$11K	Buy	+153	New	+$11.4K	﹤0.01%	1822

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Wipfli Financial Advisors's NARI Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Inari Medical, Inc. Common Stock (NARI) in Q3 2022: 153 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings.

240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

Wipfli Financial Advisors held 153 shares of Inari Medical, Inc. Common Stock worth $11K as of Q3 2022.
Inari Medical, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
Inari Medical, Inc. Common Stock made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1822 holding.
240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.